- Active not recruitingPHASE2
Phase 2 Placebo-Controlled Study to Assess the Safety and Efficacy of ESK-001 in Active Systemic Lupus Erythematosus
This study is looking into a new medication called ESK-001 for adults with an active form of lupus (SLE). We want to see if it's safe and helps improve symptoms compared to a dummy drug (placebo).
For: SLEUnited States · Argentina · Bulgaria - Active not recruitingPHASE2
Open-Label Extension Study to Evaluate the Long Term Safety and Efficacy of ESK-001 in Plaque Psoriasis
This study looks at a new psoriasis medicine called envudeucitinib. It's for people who have already taken part in an earlier study of this medicine. We want to see how safe and helpful it is over a longer time for widespread plaque psoriasis.
For: Plaque PsoriasisUnited States · Canada